{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:19:35Z","timestamp":1778703575076,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11030-023-10729-0","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T04:30:50Z","timestamp":1702355450000},"page":"3011-3026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A novel strategy to bind pyrimidine sulfonamide derivatives with odd even chains: exploration of their design, synthesis and biological activity evaluation"],"prefix":"10.1007","volume":"28","author":[{"given":"Meng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiankang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chichong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guofan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"key":"10729_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-Cancer J Clin 71:209\u2013249","journal-title":"CA-Cancer J Clin"},{"key":"10729_CR2","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3390\/biom12121843","volume":"12","author":"M Hawash","year":"2022","unstructured":"Hawash M (2022) Recent advances of tubulin inhibitors targeting the colchicine binding site for cancer therapy. Biomolecules 12:1843","journal-title":"Biomolecules"},{"key":"10729_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-023-10106-1","author":"A Sharma","year":"2023","unstructured":"Sharma A, Sharma D, Saini N, Sharma SV, Thakur VK, Goyal RK, Sharma PC (2023) Recent advances in synthetic strategies and SAR of thiazolidin-4-one containing molecules in cancer therapeutics. Cancer Metastasis Rev. https:\/\/doi.org\/10.1007\/s10555-023-10106-1","journal-title":"Cancer Metastasis Rev"},{"key":"10729_CR4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13065-022-00839-5","volume":"16","author":"M Hawash","year":"2022","unstructured":"Hawash M, Jaradat N, Eid AM, Abubaker A, Mufleh O, Al-Hroub Q, Sobuh S (2022) Synthesis of novel isoxazole\u2013carboxamide derivatives as promising agents for melanoma and targeted nano-emulgel conjugate for improved cellular permeability. BMC Chem 16:47","journal-title":"BMC Chem"},{"key":"10729_CR5","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.3390\/cancers15102721","volume":"15","author":"M Kciuk","year":"2023","unstructured":"Kciuk M, Yahya EB, Mohamed Ibrahim Mohamed M, Rashid S, Iqbal MO, Kontek R, Abdulsamad MA, Allaq AA (2023) Recent advances in molecular mechanisms of cancer immunotherapy. Cancers 15:2721","journal-title":"Cancers"},{"key":"10729_CR6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1055\/a-0898-7347","volume":"69","author":"M Hawash","year":"2019","unstructured":"Hawash M (2019) Highlights on specific biological targets; cyclin-dependent kinases, epidermal growth factor receptors, ras protein, and cancer stem cells in anticancer drug development. Drug Res 69:471\u2013478","journal-title":"Drug Res"},{"key":"10729_CR7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104249","volume":"104","author":"H Haffez","year":"2020","unstructured":"Haffez H, Taha H, Rabie MA, Awad SM, Zohny YM (2020) Synthesis, biological evaluation and molecular docking studies of novel thiopyrimidine analogue as apoptotic agent with potential anticancer activity. Bioorg Chem 104:104249","journal-title":"Bioorg Chem"},{"key":"10729_CR8","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2021.132256","volume":"92","author":"EV Filho","year":"2021","unstructured":"Filho EV, Pinheiro EMC, Pinheiro S, Greco SJ (2021) Aminopyrimidines: recent synthetic procedures and anticancer activities. Tetrahedron 92:132256","journal-title":"Tetrahedron"},{"key":"10729_CR9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.mencom.2020.03.024","volume":"30","author":"TP Trofimova","year":"2020","unstructured":"Trofimova TP, Orlova MA, Tafeenko VA, Proshin AN, Glazkova IS, Pankratov DA (2020) Mono- and binuclear chloride complexes of bismuth(iii) with 2-aminopyrimidine cations depending on specific synthetic route. Mendeleev Commun 30:202\u2013204","journal-title":"Mendeleev Commun"},{"key":"10729_CR10","doi-asserted-by":"crossref","first-page":"2203879","DOI":"10.1080\/14756366.2023.2203879","volume":"38","author":"M Mahnashi","year":"2023","unstructured":"Mahnashi M, Alshahrani MM, Al Ali A, Asiri A, Abou-Salim MA (2023) Novel Glu-based pyrazolo [3,4-d]pyrimidine analogues: design, synthesis and biological evaluation as DHFR and TS dual inhibitors. J Enzyme Inhib Med Chem 38:2203879","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10729_CR11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bioorg.2018.11.018","volume":"84","author":"Z-R Li","year":"2019","unstructured":"Li Z-R, Suo F-Z, Hu B, Guo Y-J, Fu D-J, Yu B, Zheng Y-C, Liu H-M (2019) Identification of osimertinib (AZD9291) as a lysine specific demethylase 1 inhibitor. Bioorg Chem 84:164\u2013169","journal-title":"Bioorg Chem"},{"key":"10729_CR12","volume":"121","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang C, Zhang X, Wang J, Zhao L, Zhao D, Cheng M (2022) Design, synthesis and biological evaluation of 2-aminopyrimidine-based LSD1 inhibitors. Bioorg Chem 121:105699","journal-title":"Bioorg Chem"},{"key":"10729_CR13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bioorg.2018.01.008","volume":"77","author":"R Chikhale","year":"2018","unstructured":"Chikhale R, Thorat S, Choudhary RK, Gadewal N, Khedekar P (2018) Design, synthesis and anticancer studies of novel aminobenzazolyl pyrimidines as tyrosine kinase inhibitors. Bioorg Chem 77:84\u2013100","journal-title":"Bioorg Chem"},{"key":"10729_CR14","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1080\/14756366.2022.2046567","volume":"37","author":"L Yan","year":"2022","unstructured":"Yan L, Wang Q, Liu L, Le Y (2022) Design, synthesis and biological evaluation of a series of dianilinopyrimidines as EGFR inhibitors. J Enzyme Inhib Med Chem Chem 37:832\u2013843","journal-title":"J Enzyme Inhib Med Chem Chem"},{"key":"10729_CR15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105918","volume":"126","author":"AK Farag","year":"2022","unstructured":"Farag AK, Ahn BS, Yoo JS, Karam R, Roh EJ (2022) Design, synthesis, and biological evaluation of pseudo-bicyclic pyrimidine-based compounds as potential EGFR inhibitors. Bioorg Chem 126:105918","journal-title":"Bioorg Chem"},{"key":"10729_CR16","doi-asserted-by":"crossref","first-page":"2169282","DOI":"10.1080\/14756366.2023.2169282","volume":"38","author":"B Yang","year":"2023","unstructured":"Yang B, Quan Y, Zhao W, Ji Y, Yang X, Li J, Li Y, Liu X, Wang Y, Li Y (2023) Design, synthesis and biological evaluation of 2-((4-sulfamoylphenyl)amino)-pyrrolo [2,3-d]pyrimidine derivatives as CDK inhibitors. J Enzyme Inhib Med Chem Chem 38:2169282","journal-title":"J Enzyme Inhib Med Chem Chem"},{"key":"10729_CR17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10549-017-4385-3","volume":"166","author":"D Kwapisz","year":"2017","unstructured":"Kwapisz D (2017) Cyclin-dependent kinase 4\/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib. Breast Cancer Res Treat 166:41\u201354","journal-title":"Breast Cancer Res Treat"},{"key":"10729_CR18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41573-021-00195-4","volume":"20","author":"P Cohen","year":"2022","unstructured":"Cohen P, Cross D, J\u00e4nne PA (2022) Kinase drug discovery 20 years after imatinib. Nat Rev Drug Discov 20:551","journal-title":"Nat Rev Drug Discov"},{"key":"10729_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41571-019-0287-0","volume":"17","author":"BG Carlisle","year":"2020","unstructured":"Carlisle BG, Zheng T, Kimmelman J (2020) Imatinib and the long tail of targeted drug development. Nat Rev Clin Oncol 17:1\u20133","journal-title":"Nat Rev Clin Oncol"},{"key":"10729_CR20","first-page":"654","volume":"15","author":"P Sidaway","year":"2018","unstructured":"Sidaway P (2018) Erlotinib effective in the neoadjuvant setting. Nat Rev Clin Oncol 15:654\u2013654","journal-title":"Nat Rev Clin Oncol"},{"key":"10729_CR21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lungcan.2017.02.009","volume":"106","author":"S-W Hong","year":"2017","unstructured":"Hong S-W, Park N-S, Noh MH, Shim JA, Ahn B-N, Kim YS, Kim D, Lee H-K, Hur DY (2017) Combination treatment with erlotinib and ampelopsin overcomes erlotinib resistance in NSCLC cells via the Nox2-ROS-Bim pathway. Lung Cancer 106:115\u2013124","journal-title":"Lung Cancer"},{"key":"10729_CR22","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMc1816595","volume":"380","author":"Z Mccaw","year":"2019","unstructured":"Mccaw Z et al (2019) Palbociclib and fulvestrant in breast cancer. N Engl J Med 380:796\u2013797","journal-title":"N Engl J Med"},{"key":"10729_CR23","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa1607303","volume":"375","author":"RS Finn","year":"2016","unstructured":"Finn RS, Martin M, Rugo HS, Jones S, Im S-A, Gelmon K, Harbeck N, Lipatov ON, Walshe JM, Moulder S, Gauthier E, Lu DR, Randolph S, Di\u00e9ras V, Slamon DJ (2016) Palbociclib and letrozole in advanced breast cancer. N Engl J Med 375:1925\u20131936","journal-title":"N Engl J Med"},{"key":"10729_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.615146","author":"C Liang","year":"2021","unstructured":"Liang C, Yu X, Xiong N, Zhang Z, Sun Z, Dong Y (2021) Pictilisib enhances the antitumor effect of doxorubicin and prevents tumor-mediated bone destruction by blockade of PI3K\/AKT Pathway. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.615146","journal-title":"Front Oncol"},{"key":"10729_CR25","doi-asserted-by":"crossref","unstructured":"(2016) Pictilisib plus anastrozole reduces proliferation in ER+ breast cancer. Cancer Discov 6: 471\u2013471.","DOI":"10.1158\/2159-8290.CD-RW2016-055"},{"key":"10729_CR26","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0145-2126(86)90331-0","volume":"10","author":"PA Cassileth","year":"1986","unstructured":"Cassileth PA, Gale RP (1986) Amsacrine: a review. Leuk Res 10:1257\u20131265","journal-title":"Leuk Res"},{"key":"10729_CR27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/molecules26030552","volume":"26","author":"BC Baguley","year":"2021","unstructured":"Baguley BC, Drummond CJ, Chen YY, Finlay GJ (2021) DNA-binding anticancer drugs: one target. Two Actions Molecules 26:552","journal-title":"Two Actions Molecules"},{"key":"10729_CR28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejmech.2019.03.002","volume":"171","author":"S Rostamizadeh","year":"2019","unstructured":"Rostamizadeh S, Daneshfar Z, Moghimi H (2019) Synthesis of sulfamethoxazole and sulfabenzamide metal complexes; evaluation of their antibacterial activity. Eur J Med Chem 171:364\u2013371","journal-title":"Eur J Med Chem"},{"key":"10729_CR29","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1093\/jac\/dkac304","volume":"77","author":"MJ Lasko","year":"2022","unstructured":"Lasko MJ, Tabor-Rennie JL, Nicolau DP, Kuti JL (2022) Trimethoprim\/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model. J Antimicrob Chemother 77:3187\u20133193","journal-title":"J Antimicrob Chemother"},{"key":"10729_CR30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bcp.2019.01.007","volume":"162","author":"MR Mooney","year":"2019","unstructured":"Mooney MR, Geerts D, Kort EJ, Bachmann AS (2019) Anti-tumor effect of sulfasalazine in neuroblastoma. Biochem Pharmacol 162:237\u2013249","journal-title":"Biochem Pharmacol"},{"key":"10729_CR31","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.3390\/cancers15082363","volume":"15","author":"L Kerkhove","year":"2023","unstructured":"Kerkhove L, Geirnaert F, Rifi AL, Law KL, Guti\u00e9rrez A, Oudaert I, Corbet C, Gevaert T, Dufait I, De Ridder M (2023) Repurposing sulfasalazine as a radiosensitizer in hypoxic human colorectal cancer. Cancers 15:2363","journal-title":"Cancers"},{"key":"10729_CR32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/molecules28010381","volume":"28","author":"M Giannetti","year":"2023","unstructured":"Giannetti M, Canale VC, Micheli L, Fiori M, Mazzuca C, Palleschi A (2023) An insight into the degradation processes of the anti-hypertensive drug furosemide. Molecules 28:381","journal-title":"Molecules"},{"key":"10729_CR33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106585","volume":"137","author":"MF Harras","year":"2023","unstructured":"Harras MF, Sabour R, Farghaly TA, Ibrahim MH (2023) Drug repurposing approach in developing new furosemide analogs as antimicrobial candidates and anti-PBP: design, synthesis, and molecular docking. Bioorg Chem 137:106585","journal-title":"Bioorg Chem"},{"key":"10729_CR34","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027486","volume":"12","author":"CM Mobley","year":"2023","unstructured":"Mobley CM, Bryan AS, Moran AE, Derington CG, Zhang Y, Bellows BK (2023) Fixed-dose combination medication use among us adults with hypertension: a missed opportunity. J Am Heart Assoc 12:e027486","journal-title":"J Am Heart Assoc"},{"key":"10729_CR35","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.3390\/molecules28134952","volume":"28","author":"S Godesi","year":"2023","unstructured":"Godesi S, Nada H, Lee J, Kang J-H, Kim S-Y, Choi Y, Lee K (2023) Integration of hybridization strategies in pyridine-urea scaffolds for novel anticancer agents: design, synthesis, and mechanistic insights. Molecules 28:4952","journal-title":"Molecules"},{"key":"10729_CR36","volume":"203","author":"X-J Shi","year":"2020","unstructured":"Shi X-J, Wang S, Li X-J, Yuan X-H, Cao L-J, Yu B, Liu H-M (2020) Discovery of tofacitinib derivatives as orally active antitumor agents based on the scaffold hybridization strategy. Eur J Med Chem 203:112601","journal-title":"Eur J Med Chem"},{"key":"10729_CR37","volume":"168","author":"M-H Guo","year":"2023","unstructured":"Guo M-H, Wen P, Xiao Y, Ji W-S, Zhou X-L, Gao F, Shan L-H (2023) Design, synthesis and anti-inflammatory activity of diterpenoid alkaloids and non-steroidal anti-inflammatory drug hybrids based on molecular hybridization strategy. Fitoterapia 168:105536","journal-title":"Fitoterapia"},{"key":"10729_CR38","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135477","volume":"1285","author":"M Hawash","year":"2023","unstructured":"Hawash M, Ergun SG, Kahraman DC, Olgac A, Hamel E, Cetin-Atalay R, Baytas SN (2023) Novel indole-pyrazole hybrids as potential tubulin-targeting agents; synthesis, antiproliferative evaluation, and molecular modeling studies. J Mol Struct 1285:135477","journal-title":"J Mol Struct"},{"key":"10729_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2016.02.012","volume":"107","author":"F Cortese","year":"2016","unstructured":"Cortese F, Gesualdo M, Cortese A, Carbonara S, Devito F, Zito A, Ricci G, Scicchitano P, Ciccone MM (2016) Rosuvastatin: beyond the cholesterol-lowering effect. Pharmacol Res 107:1\u201318","journal-title":"Pharmacol Res"},{"key":"10729_CR40","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.fct.2018.11.041","volume":"123","author":"D Tewari","year":"2019","unstructured":"Tewari D, Rawat P, Singh PK (2019) Adverse drug reactions of anticancer drugs derived from natural sources. Food Chem Toxicol 123:522\u2013535","journal-title":"Food Chem Toxicol"},{"key":"10729_CR41","volume":"134","author":"S Amin","year":"2023","unstructured":"Amin S, Sheikh KA, Iqubal A, Ahmed Khan M, Shaquiquzzaman M, Tasneem S, Khanna S, Najmi AK, Akhter M, Haque A, Anwer T, Mumtaz Alam M (2023) Synthesis, in-Silico studies and biological evaluation of pyrimidine based thiazolidinedione derivatives as potential anti-diabetic agent. Bioorg Chem 134:106449","journal-title":"Bioorg Chem"},{"key":"10729_CR42","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1080\/01480545.2021.1935397","volume":"45","author":"M Hawash","year":"2022","unstructured":"Hawash M, Qneibi M, Jaradat N, Abualhasan M, Amer J, Amer ELH, Ibraheem T, Hindieh S, Tarazi S, Sobuh S (2022) The impact of filtered water-pipe smoke on healthy versus cancer cells and their neurodegenerative role on AMPA receptor. Drug Chem Toxicol 45:2292\u20132300","journal-title":"Drug Chem Toxicol"},{"key":"10729_CR43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) Software news and update AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461","journal-title":"J Comput Chem"},{"key":"10729_CR44","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","volume":"19","author":"GM Morris","year":"2015","unstructured":"Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJJJoCC (2015) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19:1639\u20131662","journal-title":"J Comput Chem"},{"key":"10729_CR45","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1021\/acsmedchemlett.8b00167","volume":"9","author":"S Shen","year":"2018","unstructured":"Shen S, He X, Yang Z, Zhang L, Liu Y, Zhang Z, Wang W, Liu W, Li Y, Huang D, Sun K, Ni X, Yang X, Chu X, Cui Y, Lv Q, Lan J, Zhou F (2018) Discovery of an orally bioavailable dual pi3k\/mtor inhibitor based on sulfonyl-substituted morpholinopyrimidines. ACS Med Chem Lett 9:719\u2013724","journal-title":"ACS Med Chem Lett"},{"key":"10729_CR46","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1021\/acs.jmedchem.0c01652","volume":"64","author":"H Cheng","year":"2021","unstructured":"Cheng H, Orr STM, Bailey S, Brooun A, Chen P, Deal JG, Deng YL, Edwards MP, Gallego GM, Grodsky N, Huang B, Jalaie M, Kaiser S, Kania RS, Kephart SE, Lafontaine J, Ornelas MA, Pairish M, Planken S, Shen H, Sutton S, Zehnder L, Almaden CD, Bagrodia S, Falk MD, Gukasyan HJ, Ho C, Kang X, Kosa RE, Liu L, Spilker ME, Timofeevski S, Visswanathan R, Wang Z, Meng F, Ren S, Shao L, Xu F, Kath JC (2021) Structure-based drug design and synthesis of pi3k\u03b1-selective inhibitor (PF-06843195). J Med Chem 64:644\u2013661","journal-title":"J Med Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-023-10729-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-023-10729-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-023-10729-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T14:26:20Z","timestamp":1733149580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-023-10729-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10729"],"URL":"https:\/\/doi.org\/10.1007\/s11030-023-10729-0","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,12]]},"assertion":[{"value":"19 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}